Author

F. Léger

Observed names: F LEGER, F Leger, F Léger, F. Leger, Fr??d??ric Leger

Institutions: Université Toulouse III - Paul Sabatier, École Nationale Vétérinaire de Toulouse, Institut Claudius Regaud

Observed institutions: Université Toulouse III - Paul Sabatier, École Nationale Vétérinaire de Toulouse, Erasmus MC, Centre Hospitalier Universitaire de Limoges, Institut Claudius Regaud, National Cancer Institute, Hôpital Universitaire Dupuytren, Erasmus MC Cancer Institute, Daniel den Hoed Kliniek, Institut de Recherche Pierre Fabre (France)

OpenAlex ID: A5108419350

I.V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipients

2004 · L Nguyen, D Fuller, et al. · Bone Marrow Transplantation · 143

Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study

2005 · L. Nguyen, F. Leger, et al. · Cancer Chemotherapy and Pharmacology · 105

Population Pharmacokinetic Modeling of Oral Cyclosporin Using NONMEM

2004 · A. Rousseau, F. Léger, et al. · Therapeutic Drug Monitoring · 93

Maximum A Posteriori Bayesian Estimation of Oral Cyclosporin Pharmacokinetics in Patients with Stable Renal Transplants

2002 · Fr??d??ric Leger, Jean Debord, et al. · Clinical Pharmacokinetics · 59

Mechanism-based models for topotecan-induced neutropenia

2004 · F LEGER, W LOOS, et al. · Clinical Pharmacology & Therapeutics · 42

Factors affecting pharmacokinetic variability of oral topotecan: a population analysis

2004 · F Léger, W J Loos, et al. · British Journal of Cancer · 35

Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC0–12 monitoring in cardiac transplant recipients over the first year post-transplantation

2003 · C. Monchaud, A. Rousseau, et al. · European Journal of Clinical Pharmacology · 33

Impact of the biochemical assay for serum creatinine measurement on the individual carboplatin dosing

2002 · F. Léger, S. Séronie-Vivien, et al. · European Journal of Cancer · 31

Exposure equivalence between IV (0.8 mg/kg) and oral (1 mg/kg) busulfan in adult patients

2009 · F. Léger, L. Nguyen, et al. · European Journal of Clinical Pharmacology · 26

Pharmacokinetics of low-dose carboplatin and applicability of a method of calculation for estimating individual drug clearance

2003 · M.C. Etienne, F. Leger, et al. · Annals of Oncology · 12

Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study

2006 · J. Bonneterre, M. Campone, et al. · Cancer Chemotherapy and Pharmacology · 9

Population PK/PD Analysis

2010 · D. Concordet, C. Ané, et al. · Informa Healthcare eBooks · 1

Population PK/PD Analysis

2012 · D Concordet, C Ané, et al. · CRC Press eBooks

Pharmacokinetic-pharmacodynamic models for topotecan-induced neutropenia

2004 · E. Chatelut, W. J. Loos, et al. · Journal of Clinical Oncology

Works count: 14

Citation count: 589

H-index: 10

I10-index: 10